IDEAS home Printed from https://ideas.repec.org/p/zbw/udewwd/142.html
   My bibliography  Save this paper

Marktzugang und Preisbildung auf Arzneimittelmärkten im internationalen Vergleich

Author

Listed:
  • Wasem, Jürgen
  • Niebuhr, Dea
  • Greß, Stefan

Abstract

Die vorliegende Untersuchung befasst sich zunächst mit einem internationalen Vergleich der Regulierung auf Arzneimittelmärkten. Nach einer Auswertung und Analyse von Preisvergleichsstudien untersucht sie international vergleichend Erstattungsregulierungen und Preisregulierungen. Hierbei wird insbesondere eine Unterscheidung in Systeme zentraler Regulierung und Systeme dezentraler Regulierung getroffen. Anschließend werden aufbauend auf den international vergleichenden Analysen drei Szenarien mit unterschiedlicher Wettbewerbs-intensität entwickelt und hinsichtlich ihrer möglichen Auswirkungen für unterschiedliche Typen von pharmazeutischen Herstellern, für die Krankenkassen und für die Patienten und Versicherten analysiert.

Suggested Citation

  • Wasem, Jürgen & Niebuhr, Dea & Greß, Stefan, 2005. "Marktzugang und Preisbildung auf Arzneimittelmärkten im internationalen Vergleich," IBES Diskussionsbeiträge 142, University of Duisburg-Essen, Institute of Business and Economic Studie (IBES).
    • Handle: RePEc:zbw:udewwd:142
    as

    Download full text from publisher

    File URL: https://www.econstor.eu/bitstream/10419/23146/1/142.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Michael Dickson & Jeremy Hurst & Stephane Jacobzone, 2003. "Survey of Pharmacoeconomic Assessment Activity in Eleven Countries," OECD Health Working Papers 4, OECD Publishing.
    2. Mark Nuijten & Joszef Kosa, 2004. "Pricing of pharmaceuticals," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 5(2), pages 110-115, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. repec:ces:ifodic:v:4:y:2006:i:2:p:14567506 is not listed on IDEAS
    2. Klingler, Corinna & Shah, Sara M.B. & Barron, Anthony J.G. & Wright, John S.F., 2013. "Regulatory space and the contextual mediation of common functional pressures: Analyzing the factors that led to the German Efficiency Frontier approach," Health Policy, Elsevier, vol. 109(3), pages 270-280.
    3. Christine de Mazières & Valérie Paris, 2004. "La régulation de l’industrie pharmaceutique," Revue d'Économie Financière, Programme National Persée, vol. 76(3), pages 241-265.
    4. Verniers, Isabel & Stremersch, Stefan & Croux, Christophe, 2011. "The global entry of new pharmaceuticals: A joint investigation of launch window and price," International Journal of Research in Marketing, Elsevier, vol. 28(4), pages 295-308.
    5. Panos Kanavos & Olivier Wouters & John S. F. Wright & Anthony J. G. Barron & Sara M. B. Shah & Corinna Klingler, 2017. "Convergence, Divergence and Hybridity: A Regulatory Governance Perspective on Health Technology Assessment in England and Germany," Global Policy, London School of Economics and Political Science, vol. 8(s2), pages 69-75, March.
    6. Christine M. McDonough & Tor D. Tosteson & Anna N. A. Tosteson & Alan M. Jette & Margaret R. Grove & James N. Weinstein, 2011. "A Longitudinal Comparison of 5 Preference-Weighted Health State Classification Systems in Persons with Intervertebral Disk Herniation," Medical Decision Making, , vol. 31(2), pages 270-280, March.
    7. Stefan Greß & Jürgen Wasem & Dea Niebuhr, 2006. "Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance," ifo DICE Report, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 4(2), pages 39-47, 07.
    8. Stefan Greß & Jürgen Wasem & Dea Niebuhr, 2006. "Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance," ifo DICE Report, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 4(02), pages 39-47, July.
    9. Mark Nuijten, 2007. "Pricing matrix model: dealing with uncertainty," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 8(4), pages 333-337, December.
    10. repec:bla:glopol:v:8:y:2017:i::p:69-75 is not listed on IDEAS
    11. García-Alonso, M. D. C. & Mariñoso, B. G., 2005. "The relationship of drug reimbursement with the price and the quality of pharmaceutical innovations," Working Papers 05/02, Department of Economics, City University London.
    12. Christine McDonough & Anna Tosteson, 2007. "Measuring Preferences for Cost-Utility Analysis," PharmacoEconomics, Springer, vol. 25(2), pages 93-106, February.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:zbw:udewwd:142. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ZBW - Leibniz Information Centre for Economics (email available below). General contact details of provider: https://edirc.repec.org/data/fwessde.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.